Literature DB >> 14603337

MLL fusion partners AF4 and AF9 interact at subnuclear foci.

F Erfurth1, C S Hemenway, A C de Erkenez, P H Domer.   

Abstract

The MLL gene is involved in translocations associated with both acute lymphoblastic and acute myelogenous leukemia. These translocations fuse MLL with one of over 30 partner genes. Collectively, the MLL partner genes do not share a common structural motif or biochemical function. We have identified a protein interaction between the two most common MLL fusion partners AF4 and AF9. This interaction is restricted to discrete nuclear foci we have named 'AF4 bodies'. The AF4 body is non-nucleolar and is not coincident with any known nuclear structures we have examined. The AF4-AF9 interaction is maintained by the MLL-AF4 fusion protein, and expression of the MLL-AF4 fusion can alter the subnuclear localization of AF9. In view of other research indicating that other MLL fusion partners also interact with one another, these results suggest that MLL fusion partners may participate in a web of protein interactions with a common functional goal. The disruption of this web of interactions by fusion with MLL may be important to leukemogenesis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14603337     DOI: 10.1038/sj.leu.2403200

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


  37 in total

1.  Down-regulation of homeobox genes MEIS1 and HOXA in MLL-rearranged acute leukemia impairs engraftment and reduces proliferation.

Authors:  Kira Orlovsky; Alexander Kalinkovich; Tanya Rozovskaia; Elias Shezen; Tomer Itkin; Hansjuerg Alder; Hatice Gulcin Ozer; Letizia Carramusa; Abraham Avigdor; Stefano Volinia; Arthur Buchberg; Alex Mazo; Orit Kollet; Corey Largman; Carlo M Croce; Tatsuya Nakamura; Tsvee Lapidot; Eli Canaani
Journal:  Proc Natl Acad Sci U S A       Date:  2011-04-25       Impact factor: 11.205

2.  Dot1a-AF9 complex mediates histone H3 Lys-79 hypermethylation and repression of ENaCalpha in an aldosterone-sensitive manner.

Authors:  Wenzheng Zhang; Xuefeng Xia; Mary Rose Reisenauer; Charles S Hemenway; Bruce C Kone
Journal:  J Biol Chem       Date:  2006-04-24       Impact factor: 5.157

3.  Mineralocorticoid receptor antagonizes Dot1a-Af9 complex to increase αENaC transcription.

Authors:  Xi Zhang; Qiaoling Zhou; Lihe Chen; Stefan Berger; Hongyu Wu; Zhou Xiao; David Pearce; Xiaodong Zhou; Wenzheng Zhang
Journal:  Am J Physiol Renal Physiol       Date:  2013-09-11

4.  A role for the MLL fusion partner ENL in transcriptional elongation and chromatin modification.

Authors:  Dorothee Mueller; Christian Bach; Deniz Zeisig; Maria-Paz Garcia-Cuellar; Sara Monroe; Arun Sreekumar; Rong Zhou; Alexey Nesvizhskii; Arul Chinnaiyan; Jay L Hess; Robert K Slany
Journal:  Blood       Date:  2007-09-12       Impact factor: 22.113

5.  Aberrant chromatin at genes encoding stem cell regulators in human mixed-lineage leukemia.

Authors:  Matthew G Guenther; Lee N Lawton; Tatiana Rozovskaia; Garrett M Frampton; Stuart S Levine; Thomas L Volkert; Carlo M Croce; Tatsuya Nakamura; Eli Canaani; Richard A Young
Journal:  Genes Dev       Date:  2008-12-15       Impact factor: 11.361

6.  Af9/Mllt3 interferes with Tbr1 expression through epigenetic modification of histone H3K79 during development of the cerebral cortex.

Authors:  Nicole Büttner; Steven A Johnsen; Sebastian Kügler; Tanja Vogel
Journal:  Proc Natl Acad Sci U S A       Date:  2010-03-26       Impact factor: 11.205

7.  Molecular targeting of MLL-rearranged leukemia cell lines with the synthetic peptide PFWT synergistically enhances the cytotoxic effect of established chemotherapeutic agents.

Authors:  Cecily A Bennett; Amanda C Winters; Nisha N Barretto; Charles S Hemenway
Journal:  Leuk Res       Date:  2009-02-20       Impact factor: 3.156

8.  The AF4-mimetic peptide, PFWT, induces necrotic cell death in MV4-11 leukemia cells.

Authors:  Christine M Palermo; Cecily A Bennett; Amanda C Winters; Charles S Hemenway
Journal:  Leuk Res       Date:  2007-09-17       Impact factor: 3.156

9.  Novel sub-cellular localizations and intra-molecular interactions may define new functions of Mixed Lineage Leukemia protein.

Authors:  Amit Mahendra Karole; Swathi Chodisetty; Aamir Ali; Nidhi Kumari; Shweta Tyagi
Journal:  Cell Cycle       Date:  2018-12-10       Impact factor: 4.534

10.  Misguided transcriptional elongation causes mixed lineage leukemia.

Authors:  Dorothee Mueller; María-Paz García-Cuéllar; Christian Bach; Sebastian Buhl; Emanuel Maethner; Robert K Slany
Journal:  PLoS Biol       Date:  2009-11-24       Impact factor: 8.029

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.